WO1999057246A8 - Animal cell culture media comprising non-animal or plant-derived nutrients - Google Patents

Animal cell culture media comprising non-animal or plant-derived nutrients

Info

Publication number
WO1999057246A8
WO1999057246A8 PCT/US1999/009574 US9909574W WO9957246A8 WO 1999057246 A8 WO1999057246 A8 WO 1999057246A8 US 9909574 W US9909574 W US 9909574W WO 9957246 A8 WO9957246 A8 WO 9957246A8
Authority
WO
WIPO (PCT)
Prior art keywords
animal
cell culture
plant
culture media
media
Prior art date
Application number
PCT/US1999/009574
Other languages
French (fr)
Other versions
WO1999057246A9 (en
WO1999057246A1 (en
Inventor
Paul J Price
Steve Gorfien
Douglas Danner
Mark Plavsic
Original Assignee
Life Technologies Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Life Technologies Inc filed Critical Life Technologies Inc
Publication of WO1999057246A1 publication Critical patent/WO1999057246A1/en
Publication of WO1999057246A8 publication Critical patent/WO1999057246A8/en
Publication of WO1999057246A9 publication Critical patent/WO1999057246A9/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0018—Culture media for cell or tissue culture
    • C12N5/0043—Medium free of human- or animal-derived components
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/05—Inorganic components
    • C12N2500/10—Metals; Metal chelators
    • C12N2500/12—Light metals, i.e. alkali, alkaline earth, Be, Al, Mg
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/05—Inorganic components
    • C12N2500/10—Metals; Metal chelators
    • C12N2500/20—Transition metals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/30—Organic components
    • C12N2500/32—Amino acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/30—Organic components
    • C12N2500/36—Lipids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/30—Organic components
    • C12N2500/40—Nucleotides, nucleosides, bases
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/70—Undefined extracts
    • C12N2500/74—Undefined extracts from fungi, e.g. yeasts
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/70—Undefined extracts
    • C12N2500/76—Undefined extracts from plants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/90—Serum-free medium, which may still contain naturally-sourced components
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/11—Epidermal growth factor [EGF]

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

The present invention provides serum-free cell culture media formulations which are capable of supporting the in vitro cultivation of animal cells. The media comprise at least one nutrient of non-animal derivation, such as at least one plant peptide and/or at least one non-animal or plant lipid and/or fatty acid. The media may further optionally comprise an enzymatic digest or extract of yeast cells. The present invention also provides methods of cultivating animal cells in vitro using these cell culture media formulations. In addition, the media of the present invention can be used for growth of animal cells for virus production.
PCT/US1999/009574 1998-05-01 1999-05-03 Animal cell culture media comprising non-animal or plant-derived nutrients WO1999057246A1 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US7080798A 1998-05-01 1998-05-01
US09/070,807 1998-05-01
US30295399A 1999-04-30 1999-04-30
US09/302,953 1999-04-30

Publications (3)

Publication Number Publication Date
WO1999057246A1 WO1999057246A1 (en) 1999-11-11
WO1999057246A8 true WO1999057246A8 (en) 2000-10-12
WO1999057246A9 WO1999057246A9 (en) 2001-06-21

Family

ID=26751514

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US1999/009574 WO1999057246A1 (en) 1998-05-01 1999-05-03 Animal cell culture media comprising non-animal or plant-derived nutrients

Country Status (1)

Country Link
WO (1) WO1999057246A1 (en)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6475725B1 (en) 1997-06-20 2002-11-05 Baxter Aktiengesellschaft Recombinant cell clones having increased stability and methods of making and using the same
AT409379B (en) 1999-06-02 2002-07-25 Baxter Ag MEDIUM FOR PROTEIN- AND SERUM-FREE CELL CULTURE
WO2001066560A2 (en) * 2000-03-07 2001-09-13 Forbes Medi-Tech Inc. Novel derivatives comprising phytosterols and/or phytostanols and alpha-lipoic and use thereof in treating or preventing cardiovascular disease, its underlying conditions and other disorders
EP1181865A1 (en) * 2000-08-23 2002-02-27 Universite Catholique De Louvain Cryoprotective solutions
EP1520008B1 (en) 2002-07-09 2012-09-05 Baxter International Inc. Animal protein free media for cultivation of cells
GB0304799D0 (en) 2003-03-03 2003-04-09 Glaxosmithkline Biolog Sa Novel method
US20060094104A1 (en) 2004-10-29 2006-05-04 Leopold Grillberger Animal protein-free media for cultivation of cells
FR2879214A1 (en) 2004-12-14 2006-06-16 Pierre Fabre Medicament Sa PEPTIDE FRACTIONS PROMOTING THE GROWTH AND SYNTHESIS OF PRODUCT (S) OF INTEREST IN CELL CULTURE AND / OR TISSUE
NL1029059C2 (en) * 2005-05-17 2006-11-20 Noord Nl Oliemolen Holding B V Peptide preparation for growing and / or growing microorganisms and / or cells.
DE102005054577A1 (en) * 2005-11-16 2007-05-24 Cognis Ip Management Gmbh Use of esters of unsaturated, physiologically active fatty acids as nutrient media for cell cultures
PL2522717T3 (en) 2006-01-04 2014-08-29 Baxalta Inc Oligopeptide-free cell culture media
US8911964B2 (en) 2006-09-13 2014-12-16 Abbvie Inc. Fed-batch method of making human anti-TNF-alpha antibody
EP2500416A1 (en) * 2006-09-13 2012-09-19 Abbott Laboratories Cell culture improvements
MY161866A (en) * 2006-09-13 2017-05-15 Abbvie Inc Cell culture improvements
WO2012149197A2 (en) 2011-04-27 2012-11-01 Abbott Laboratories Methods for controlling the galactosylation profile of recombinantly-expressed proteins
US9067990B2 (en) 2013-03-14 2015-06-30 Abbvie, Inc. Protein purification using displacement chromatography
US9150645B2 (en) 2012-04-20 2015-10-06 Abbvie, Inc. Cell culture methods to reduce acidic species
US9181572B2 (en) 2012-04-20 2015-11-10 Abbvie, Inc. Methods to modulate lysine variant distribution
WO2013176754A1 (en) 2012-05-24 2013-11-28 Abbvie Inc. Novel purification of antibodies using hydrophobic interaction chromatography
US9512214B2 (en) 2012-09-02 2016-12-06 Abbvie, Inc. Methods to control protein heterogeneity
US9206390B2 (en) 2012-09-02 2015-12-08 Abbvie, Inc. Methods to control protein heterogeneity
WO2014143205A1 (en) 2013-03-12 2014-09-18 Abbvie Inc. Human antibodies that bind human tnf-alpha and methods of preparing the same
US9017687B1 (en) 2013-10-18 2015-04-28 Abbvie, Inc. Low acidic species compositions and methods for producing and using the same using displacement chromatography
WO2014151878A2 (en) 2013-03-14 2014-09-25 Abbvie Inc. Methods for modulating protein glycosylation profiles of recombinant protein therapeutics using monosaccharides and oligosacharides
WO2014159579A1 (en) 2013-03-14 2014-10-02 Abbvie Inc. MUTATED ANTI-TNFα ANTIBODIES AND METHODS OF THEIR USE
EP3052640A2 (en) 2013-10-04 2016-08-10 AbbVie Inc. Use of metal ions for modulation of protein glycosylation profiles of recombinant proteins
US9181337B2 (en) 2013-10-18 2015-11-10 Abbvie, Inc. Modulated lysine variant species compositions and methods for producing and using the same
US9085618B2 (en) 2013-10-18 2015-07-21 Abbvie, Inc. Low acidic species compositions and methods for producing and using the same
US8946395B1 (en) 2013-10-18 2015-02-03 Abbvie Inc. Purification of proteins using hydrophobic interaction chromatography
WO2015073884A2 (en) 2013-11-15 2015-05-21 Abbvie, Inc. Glycoengineered binding protein compositions
EP3897703A2 (en) 2018-12-21 2021-10-27 Intervet International B.V. Serum free intracellular pathogen vaccine
CN110257325A (en) * 2019-05-31 2019-09-20 苏州智享众创孵化管理有限公司 A method of the in vitro culture self-healing cell based on aloe extract
US20230174996A1 (en) 2019-12-20 2023-06-08 Intervet Inc. Reassorted isa virus

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9022545D0 (en) * 1990-10-17 1990-11-28 Wellcome Found Culture medium
CA2097019C (en) * 1992-06-04 2007-07-24 Philip J. Provost Process for attenuated varicella zoster virus vaccine production

Also Published As

Publication number Publication date
WO1999057246A9 (en) 2001-06-21
WO1999057246A1 (en) 1999-11-11

Similar Documents

Publication Publication Date Title
WO1999057246A8 (en) Animal cell culture media comprising non-animal or plant-derived nutrients
AU4751697A (en) Animal cell culture media comprising plant-derived nutrients
EP0945515A3 (en) Production of proteins using homologous recombination
MX2007005132A (en) Animal protein-free media for cultivation of cells.
AR004938A1 (en) PROTEIN DERIVED FROM ALPHA-HORDOTIONINE WITH HIGH METIONIN CONTENT, NUCLEOTIDE, RNA AND DNA SEQUENCES, EXPRESSION CASSETE, BACTERIAL TRANSFORMATION VECTOR, AND TRANSFORMED VEGETABLE METHODS FROM YIDROID, CELLULA, AND CROPS OF TEID
WO2006029198A3 (en) Culturing human embryonic stem cells
ATE507283T1 (en) DRY CELLS AND CELL CULTURE REAGENTS AND METHOD FOR THE PRODUCTION THEREOF
EP2295533A3 (en) Dry powder cells and cell culture reagents and methods of production thereof
WO2001036589A3 (en) Human ex vivo immune system
GB2432846B (en) Medium and culture of embryonic stem cells
CA2264270A1 (en) Mass production of paclitaxel by changing the temperature of the medium during the plant cell culture
IL210618A (en) Cell cultures comprising isolated expanded human non-embryonic non-germ cells, pharmaceutical compositions comprising the same, methods for their preparation and methods for identifying modulators and differentiation factors
DE69939947D1 (en) METHOD OF PREPARING POLYPEPTIDES IN MUTATED ASPERGILLUS CELLS
ATE331731T1 (en) METHOD FOR PRODUCING DIPHTHERIA TOXIN
EP1849860A3 (en) Culture medium with yeast or soy bean extract as aminoacid source and no protein complexes of animal origin
WO2006015887A3 (en) Modulation of alkaloid biosynthesis in plants and plants having altered alkaloid biosynthesis
AU2003252396A1 (en) APPARATUS FOR ENVIRONMENT OF CULTIVATING/CULTURING PLANT, CULTIVATION/CULTURE METHOD and CULTIVATION/CULTURE APPARATUS
WO2000056905A3 (en) Method for enhancing and/or improving plant growth and/or yield or modifying plant architecture
CN109196091A (en) Generate the recombinant microorganism of biosurfactant
ATE462781T1 (en) CELL CULTURE MEDIA
WO2000043499A3 (en) ANTI-TRANSFORMING GROWTH FACTOR BETA (TGF-β) TREATED STEM CELL COMPOSITION AND METHOD
AU4751797A (en) Defined systems for epithelial cell culture and use thereof
BR0014671A (en) Method for the production of proteinaceous substances
HUP0101081A2 (en) Medium and method for viral propagation and growth
WO2002044355A3 (en) Protozoan expression systems for lysosomal storage disease genes

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): JP

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
AK Designated states

Kind code of ref document: C1

Designated state(s): JP

AL Designated countries for regional patents

Kind code of ref document: C1

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE

CFP Corrected version of a pamphlet front page
CR1 Correction of entry in section i

Free format text: PAT. BUL. 45/99 UNDER (30) REPLACE "NOT FURNISHED" BY "09/302953"

AK Designated states

Kind code of ref document: C2

Designated state(s): JP

AL Designated countries for regional patents

Kind code of ref document: C2

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE

COP Corrected version of pamphlet

Free format text: PAGES 1-41, DESCRIPTION, REPLACED BY NEW PAGES 1-43; PAGES 42-45, CLAIMS, REPLACED BY NEW PAGES 44-48; PAGES 1/3-3/3, DRAWINGS, REPLACED BY NEW PAGES 1/3-3/3; DUE TO LATE TRANSMITTAL BY THE RECEIVING OFFICE

122 Ep: pct application non-entry in european phase